Can the type of fluid used after bladder surgery keep cancer away?
NCT ID NCT07279792
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 150 people who had surgery for early-stage bladder cancer. After surgery, they received one of three different fluids (distilled water, normal saline, or hypertonic saline) to wash the bladder. The goal was to see if any fluid was better at preventing the cancer from coming back within 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2/3
Runs two stages together: whether the treatment works, then large-scale confirmation.
- Participants
-
150 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients of non-muscle invasive urinary bladder urothelial carcinoma amenable for complete resection Exclusion Criteria: * Patients with post-operative complications that need prolonged irrigation. * Patient who underwent incomplete resection during TURBT. * When large bladder perforation was suspected during TURBT. * Patients with chronic kidney disease. * Muscle invasive disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bladder (urothelial, transitional cell) cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain Shams University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Music and lidocaine timing: a simple recipe for a gentler cystoscopy?
- Can a Bladder-Directed biologic outsmart Treatment-Resistant bladder cancer?
- Can a Bladder-Instilled biologic keep recurrent bladder cancer at bay?
- Could a common vitamin restore immunotherapy power after antibiotics?
- Could less be more? bladder cancer trial tests stopping immunotherapy after tumors vanish
- Could bladder bacteria trigger cancer? new study investigates